Infliximab
- IVInfliximabRemicadeChimaeric monoclonal antibody to TNF
- Mechanism of Action
- Inhibits tumour necrosis factor alpha (TNF-α), a cytokine involved in systemic inflammation and the acute phase response.
Clinical Use
- Indications
- Adverse Effects